This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Procedures for purposes other than remedying health state
Z21_PROCED_PURPO_OTH_REMED_HEALTH_STATE
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
958 |
4. Check minimum number of eventsNone |
958 |
5. Include endpointsNone |
958 |
6. Filter based on genotype QC (FinnGen only) |
958 |
Control definitions (FinnGen only)
- Control exclude
- Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_SPECIFIC_PROCED_HEALTH_CARE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Z4|Z5[0-4]
Similar endpoints
↥List of similar endpoints to
Procedures for purposes other than remedying health state
based on the number of shared cases.
Similar with more cases:
- Persons encountering health services for specific procedures and health care
- Factors influencing health status and contact with health services
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 958 | 823 | 135 |
| Unadjusted period prevalence (%) | 0.25 | 0.28 | 0.06 |
| Median age at first event (years) | 49.03 | 49.23 | 47.80 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 848
- Matched controls
- 8480
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Z41.1
ICD-10 Finland
Other plastic surgery for unacceptable cosmetic appearance
16384.0
323.0
651
*
QAJ30
NOMESCO Finland
Other facelift
295.3
126.8
126
5
HAD10
NOMESCO Finland
Augmentation of breast using prosthesis
146.0
109.1
114
9
Z41.8
ICD-10 Finland
Other procedures for purposes other than remedying health state
+∞
84.8
80
*
QAJ99
NOMESCO Finland
Other aesthetic operations on skin of head or neck
+∞
81.6
77
*
QBJ00
NOMESCO Finland
Liposuction in trunk
73.5
81.3
92
14
Z41.9
ICD-10 Finland
Procedure for purposes other than remedying health state, unspecified
+∞
74.0
70
*
CBB20
NOMESCO Finland
Correction of lax skin of eyelid and resection of herniated fat
28.7
64.5
88
34
Z41
ICD-10 Finland
Procedures for purposes other than remedying health state
+∞
31.4
30
*
QAJ00
NOMESCO Finland
Liposuction in head or neck
+∞
30.4
29
*
QBJ30
NOMESCO Finland
Correction of abdominal apron
19.3
29.0
44
24
H02.3
ICD-10 Finland
Blepharochalasis
3.9
22.1
97
274
N05CF02
ATC
zolpidem; oral
2.5
21.9
209
995
V500A
ICD-9 Finland
Elective surgery for purposes other than remedying health states, Hair transplant
39.8
21.8
27
7
N05CF01
ATC
zopiclone; oral
2.2
21.5
297
1689
CBD00
NOMESCO Finland
Plastic reconstruction of eyelid using suture
61.6
21.0
24
*
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
13.5
20.3
35
27
J01MA02
ATC
ciprofloxacin; systemic
2.0
19.5
329
2015
N06AX11
ATC
mirtazapine; oral
2.1
19.3
302
1792
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.0
19.0
390
2568
Z41.2
ICD-10 Finland
Routine and ritual circumcision
+∞
18.8
18
*
DLD20
NOMESCO Finland
Rhinoplasty
45.0
18.3
22
5
N05BA12
ATC
alprazolam; oral
2.8
18.1
126
495
HAD40
NOMESCO Finland
Mastopexy
17.0
17.9
28
17
Z41.0
ICD-10 Finland
Hair transplant
+∞
17.8
17
*
Z2221
NOMESCO Finland
Medical doctor
2.0
17.3
270
1583
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
+∞
16.7
16
*
J02AC01
ATC
fluconazole; systemic
1.8
16.2
436
3097
HAD50
NOMESCO Finland
Removal of prosthetic implant from breast
21.4
16.0
23
11
N06AB04
ATC
citalopram; systemic
2.1
16.0
216
1190
J05AB11
ATC
valaciclovir; oral
2.4
15.9
149
691
Z42.1
ICD-10 Finland
Follow-up care involving plastic surgery of breast
86.7
15.6
17
*
Z50.1
ICD-10 Finland
Other physical therapy
11.6
14.8
27
24
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.9
14.8
289
1821
N06AB10
ATC
escitalopram; oral
2.1
14.8
201
1105
QDJ00
NOMESCO Finland
Liposuction in lower extremity
81.5
14.6
16
*
ZXD10
NOMESCO Finland
Scheduled procedure
1.8
14.4
344
2319
9862
FHL
Facial skin shaping surgery (Faclift)
43.2
14.1
17
*
ZZF00
NOMESCO Finland
Graft of adipose tissue
11.7
13.8
25
22
J01AA07
ATC
tetracycline; systemic
2.2
13.7
165
856
N06AX16
ATC
venlafaxine; oral
2.2
13.7
147
727
D10BA01
ATC
isotretinoin; oral
3.1
13.6
78
272
L90.5
ICD-10 Finland
Scar conditions and fibrosis of skin
9.6
13.5
27
29
R4110
NOMESCO Finland
Physiotherapy
1.9
13.4
219
1289
N05AH04
ATC
quetiapine; oral
2.2
13.3
151
766
HAD30
NOMESCO Finland
Reduction mammoplasty with transposition of areola
3.6
13.2
60
176
N05BA04
ATC
oxazepam; oral
1.9
13.1
222
1322
QAJ15
NOMESCO Finland
Browlift using video-endoscope
70.9
12.6
14
*
N06AB03
ATC
fluoxetine; oral
2.2
12.5
134
659
J01DB01
ATC
cefalexin; oral
1.9
12.4
690
5924
HAD99
NOMESCO Finland
Other plastic operation on breast
16.1
12.2
19
12
C07AA05
ATC
propranolol; systemic
2.0
12.1
186
1063
N62
ICD-10 Finland
Hypertrophy of breast
3.2
11.8
61
198
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
16.7
11.7
18
11
T85.4
ICD-10 Finland
Mechanical complication of breast prosthesis and implant
23.2
11.6
16
7
Z3226
NOMESCO Finland
Physiotherapist
2.0
11.3
154
841
Z22.3
ICD-10 Finland
Carrier of other specified bacterial diseases
25.4
11.2
15
6
DAD30
NOMESCO Finland
Plastic repair of auricle
43.9
10.9
13
*
N02AX02
ATC
tramadol; systemic, rectal
1.7
10.7
324
2291
CBD99
NOMESCO Finland
Other plastic reconstruction of eyelid
60.8
10.6
12
*
QBJ05
NOMESCO Finland
Other correction of loose or redundant skin of trunk
+∞
10.4
10
*
QAJ10
NOMESCO Finland
Browlift
23.7
10.3
14
6
N06AB06
ATC
sertraline; oral
2.2
10.3
109
535
HAD00
NOMESCO Finland
Augmentation mammoplasty
40.5
10.0
12
*
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.6
9.6
373
2794
J01MA06
ATC
norfloxacin; oral
2.0
9.6
136
751
N05BA01
ATC
diazepam; systemic, rectal
2.1
9.6
119
625
Z3231
NOMESCO Finland
Registered nurse
1.8
9.5
199
1253
E0000UV
ATC
NA
1.6
9.2
319
2314
O04.9
ICD-10 Finland
Medical abortion, complete or unspecified, without complication
2.3
9.2
85
390
ZXE10
NOMESCO Finland
More than one and less than three hours
1.6
9.1
291
2066
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.7
9.0
216
1417
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.1
8.9
106
545
Z2445
NOMESCO Finland
Psychologist
3.5
8.6
39
116
L57.4
ICD-10 Finland
Cutis laxa senilis
27.8
8.5
11
*
Z53.2
ICD-10 Finland
Procedure not carried out because of patient's decision for other and unspecified reasons
20.2
8.5
12
6
N06AB05
ATC
paroxetine; oral
2.4
8.5
68
292
EBA00
NOMESCO Finland
Extraction of tooth
0.6
8.4
114
1845
QXJ05
NOMESCO Finland
Excision of lax skin for cosmetic reasons, unspecified location
90.9
8.4
9
*
QAF00
NOMESCO Finland
Hair bearing graft of skin to scalp
90.9
8.4
9
*
J01DA01
ATC
[U] cefalexin; systemic
1.5
8.4
519
4288
M03AX01
ATC
botulinum toxin; parenteral
6.3
8.3
21
34
Z49.1
ICD-10 Finland
Extracorporeal dialysis
+∞
8.3
8
*
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
3.4
8.3
38
114
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.7
8.2
176
1113
ZXA10
NOMESCO Finland
Bilateral
1.8
8.2
146
871
Z76
ICD-10 Finland
Persons encountering health services in other circumstances
5.2
8.2
24
47
QAE20
NOMESCO Finland
Excision and repair of scar or web of skin of head or neck
11.8
8.1
14
12
H04.10
ICD-10 Finland
Dry eye syndrome
2.1
8.0
96
496
ZXE00
NOMESCO Finland
One hour or less
1.5
7.9
318
2373
S01GX01
ATC
cromoglicic acid; ophthalmic
1.7
7.9
186
1209
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.6
7.8
54
213
M01AE01
ATC
ibuprofen; systemic, rectal
1.9
7.8
766
7049
Z51.5
ICD-10 Finland
Palliative care
9.5
7.8
15
16
QAJ20
NOMESCO Finland
Subperiosteal facelift
80.7
7.4
8
*
QBJ99
NOMESCO Finland
Other aesthetic correction of skin of trunk
80.7
7.4
8
*
T90
ICPC
Diabetes non-insulin dependent
0.5
7.4
49
980
A06AC01
ATC
ispaghula (psylla seeds); oral
1.6
7.4
201
1355
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.5
7.3
447
3638
J01AA04
ATC
lymecycline; systemic
1.8
7.3
121
703
J01FF01
ATC
clindamycin; systemic
1.6
7.2
208
1424
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.5
7.2
264
1914
G03DC05
ATC
[U] tibolone; oral
2.5
7.2
56
234
N95.1
ICD-10 Finland
Menopausal and female climacteric states
1.9
7.2
112
635
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
2.1
7.2
79
393
J05AB01
ATC
aciclovir; systemic
1.6
7.2
188
1252
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.6
7.2
191
1282
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
30.3
7.2
9
*
J01FA10
ATC
azithromycin; systemic
1.5
7.1
499
4164
QBE20
NOMESCO Finland
Excision and repair of scar or web of skin of trunk
8.9
7.1
14
16
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.0
7.0
88
462
UJF30
NOMESCO Finland
Ileoscopy through colon
2.1
6.9
74
364
N06AA12
ATC
doxepin; systemic
2.6
6.9
48
192
C01CA24
ATC
epinephrine; parenteral
2.4
6.8
57
250
N03AX16
ATC
pregabalin; oral
1.6
6.8
183
1226
TK800
NOMESCO Finland
Hemodialysis
11.0
6.8
12
11
N02AJ06
ATC
codeine and paracetamol; systemic
1.5
6.8
285
2129
G03FA12
ATC
medroxyprogesterone and estrogen; systemic (progestogens and estrogens, fixed comb.)
2.2
6.8
67
320
D10AX03
ATC
azelaic acid; topical
2.1
6.7
76
384
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.5
6.7
288
2162
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
6.7
196
1346
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.5
6.7
417
3381
X59
ICD-10 Finland
Exposure to unspecified factor
1.7
6.6
132
815
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.9
6.6
91
498
M01AH05
ATC
etoricoxib; oral
1.4
6.5
482
4035
J01MA12
ATC
levofloxacin; systemic
1.7
6.5
125
764
R06AE07
ATC
cetirizine; oral
1.5
6.5
368
2924
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.1
6.5
72
363
QAJ35
NOMESCO Finland
Other correction of loose or redundant skin of head or neck
70.3
6.4
7
*
P01AB01
ATC
metronidazole; oral, rectal
1.5
6.4
346
2720
QDJ05
NOMESCO Finland
Correction of loose or redundant skin of lower extremity
+∞
6.3
6
*
D06BX01
ATC
metronidazole; topical
1.8
6.2
104
605
QAE40
NOMESCO Finland
Repair of anomaly or lesion after disease of skin of head or neck
26.9
6.2
8
*
Y5099
ICD-8 Finland
Plastic surgery for cosmetic reasons
26.9
6.2
8
*
HAE99
NOMESCO Finland
Other reconstruction of breast
6.3
6.2
15
24
ZXE20
NOMESCO Finland
More than three and less than five hours
1.9
6.2
86
473
J02AB02
ATC
ketoconazole; oral
3.1
6.2
31
102
Z3229
NOMESCO Finland
Other healthcare associate professional
2.3
6.1
53
240
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
4.4
6.1
20
46
G03FB05
ATC
norethisterone and estrogen; systemic (progestogens and estrogens, sequential prep.)
1.7
6.0
119
731
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
4.2
6.0
21
51
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40768804) Tissue Pathology biopsy report
470
3444
1.72
14.81
2.2
2.0
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
196
1117
1.95
14.25
2.3
2.3
e6/l
0.9
1.2
0.75
102
586
(3001122) Ferritin [Mass/volume] in Serum or Plasma
479
3568
1.68
13.88
2.9
2.6
ug/l
98.5
89.4
0.42
450
3331
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
467
3456
1.69
13.87
2.4
2.2
nmol/l
84.4
78.5
3.74
432
3133
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
177
999
1.95
13.16
2.2
2.4
e6/l
3.3
3.4
0.06
86
470
(3011397) Hemoglobin [Presence] in Urine by Test strip
279
1815
1.76
13.14
3.4
3.6
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
131
682
2.07
12.18
2.4
2.1
u/l
32.4
36.9
0.56
115
581
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
112
550
2.17
12.11
2.1
1.8
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
350
2476
1.65
11.85
3.6
3.1
e6/l
81.5
111.2
0.39
223
1616
(3013650) Neutrophils [#/volume] in Blood by Automated count
564
4520
1.60
11.19
7.8
7.9
e9/l
3.7
3.9
1.65
481
3926
(3044640) Blood type and Crossmatch panel - Blood
328
2310
1.64
11.16
2.1
2.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
65
260
2.61
11.13
1.5
1.7
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
216
1365
1.75
11.01
2.6
2.5
mmol/l
2.4
2.4
0.49
181
1219
(3017143) Hepatitis C virus Ab [Presence] in Serum
147
830
1.91
10.80
1.6
1.4
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
273
1856
1.66
10.57
2.9
2.6
e6/l
0.3
0.4
0.53
189
1341
(3007853) Bacteria identified in Skin by Aerobe culture
136
764
1.91
10.12
2.1
1.5
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
486
3818
1.55
10.08
5.3
5.5
e9/l
0.5
0.5
0.88
408
3297
(40768443) Skin Pathology biopsy report
75
340
2.31
9.83
1.3
1.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
220
1445
1.68
9.61
2.2
1.8
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
485
3835
1.54
9.59
5.3
5.5
e9/l
0.0
0.0
1.16
408
3309
(3002582) Erythrocytes [#/volume] in Urine
284
1998
1.60
9.40
2.9
2.6
e6/l
28.8
58.8
1.42
200
1471
(36304419) Bacteria [Presence] in Urine
267
1851
1.61
9.40
2.9
2.6
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
496
3952
1.53
9.39
5.2
5.5
e9/l
2.0
2.0
0.07
427
3490
(3013115) Eosinophils [#/volume] in Blood
498
3976
1.53
9.31
5.5
5.7
e9/l
0.2
0.2
0.12
428
3489
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
49
195
2.59
8.52
1.3
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
268
1905
1.56
8.33
1.5
1.4
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
385
2975
1.49
8.04
2.0
1.8
pmol/l
96.3
99.0
0.49
167
1432
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
153
953
1.72
8.03
6.6
5.9
—
—
—
0
0
(40758558) Short blood count panel - Blood
276
1989
1.54
8.03
6.7
5.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
644
5521
1.51
7.95
3.3
3.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
83
431
2.01
7.74
2.0
1.7
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
833
7608
1.73
7.49
14.3
11.5
%
39.8
39.7
0.19
677
5734
(3018418) pH of Serum or Plasma
297
2202
1.51
7.48
4.5
3.0
ph
7.4
7.4
0.59
41
415
(3024561) Albumin [Mass/volume] in Serum or Plasma
393
3082
1.47
7.47
4.4
3.5
g/l
36.5
36.5
0.10
366
2871
(3022096) Basophils/100 leukocytes in Blood
428
3417
1.46
7.39
5.4
5.6
%
0.7
0.7
0.52
401
3163
(3037467) Urinalysis macro (dipstick) panel - Urine
624
5364
1.47
7.21
4.2
3.9
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
441
3555
1.45
7.16
5.4
5.8
%
8.4
8.2
0.41
417
3313
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
846
7780
1.75
7.16
5.6
5.0
mu/l
1.8
2.0
0.94
790
7197
(3007164) IgA [Mass/volume] in Serum or Plasma
231
1640
1.54
7.07
1.3
1.4
g/l
2.0
2.3
3.04
125
1011
(3000991) Gas panel - Venous blood
84
455
1.93
6.95
5.7
7.0
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
150
966
1.66
6.91
2.5
2.0
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
341
2633
1.46
6.89
3.0
2.8
mmol/l
2.4
2.4
1.51
301
2328
(3003458) Phosphate [Moles/volume] in Serum or Plasma
125
773
1.71
6.71
6.3
3.2
mmol/l
1.1
1.0
0.86
114
708
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
265
1959
1.49
6.64
1.3
1.3
u/ml
1.8
1.5
0.11
65
537
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
841
7755
1.69
6.61
11.8
9.7
ml/min/173m2
83.8
83.8
0.02
670
6293
(3012095) Magnesium [Moles/volume] in Serum or Plasma
154
1010
1.63
6.59
2.9
2.6
mmol/l
0.8
0.8
0.13
142
942
(3006504) Eosinophils/100 leukocytes in Blood
436
3544
1.42
6.58
5.3
5.5
%
3.0
2.8
1.02
411
3274
(3002030) Lymphocytes/100 leukocytes in Blood
449
3680
1.41
6.42
5.3
5.5
%
29.7
29.5
0.16
422
3418
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
79
431
1.91
6.41
1.3
1.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
139
897
1.64
6.34
2.0
1.8
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
241
1763
1.49
6.32
2.1
1.9
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
749
6745
1.51
6.30
4.8
4.3
pmol/l
14.4
14.7
1.67
693
6212
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
440
3603
1.41
6.27
6.0
4.9
mmol/l
1.2
1.2
0.67
383
3020
(40768797) Stomach Pathology biopsy report
169
1147
1.57
6.26
1.2
1.2
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
406
3291
1.41
6.08
5.3
4.4
mmol/l
1.2
1.2
1.16
372
2973
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
867
8103
1.74
5.93
13.4
10.4
mg/l
22.8
20.6
0.98
639
6154
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
32
124
2.64
5.93
1.3
1.2
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
442
3647
1.39
5.91
5.2
5.3
%
55.6
56.3
0.63
415
3398
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
683
6069
1.44
5.91
7.4
6.2
u/l
72.8
74.2
0.57
650
5687
(3014765) Yersinia sp identified in Stool by Organism specific culture
54
267
2.08
5.79
1.1
1.1
—
—
—
0
0
(3044889) 12 lead EKG panel
633
5573
1.40
5.60
3.5
3.3
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
467
3912
1.38
5.59
5.6
4.8
umol/l
10.0
10.5
0.69
433
3675
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
131
861
1.60
5.54
2.3
1.9
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
90
536
1.75
5.53
1.3
1.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
54
272
2.04
5.52
1.1
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
123
801
1.61
5.40
1.8
1.6
—
—
—
0
0
(3002256) Pathology report gross observation
153
1055
1.54
5.25
1.3
1.2
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
878
8278
1.73
5.23
14.3
11.5
mmol/l
139.6
139.8
1.94
865
8052
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
47
230
2.10
5.20
1.5
1.3
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
119
776
1.61
5.20
2.2
2.4
umol/l
6.0
5.7
0.07
101
670
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
33
140
2.41
5.11
1.9
1.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
167
1183
1.50
5.04
1.9
1.5
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
161
1132
1.51
5.04
1.4
1.3
titre
678.5
612.8
0.12
27
254
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
102
646
1.65
5.01
3.4
3.5
ug/l
7.4
5.6
0.14
77
503
(3022145) Colonoscopy Study observation
133
899
1.56
4.99
1.4
1.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
52
269
1.99
4.97
1.2
1.1
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
668
5988
1.38
4.93
4.0
3.9
mm/h
9.6
11.1
2.70
629
5549
(3023103) Potassium [Moles/volume] in Serum or Plasma
879
8312
1.70
4.88
14.6
11.6
mmol/l
3.9
3.9
1.78
863
8072
(3048689) Calprotectin [Mass/mass] in Stool
150
1046
1.51
4.88
2.0
2.2
ug/g
87.2
110.8
0.70
110
817
(42870588) Differential panel, method unspecified - Blood
305
2435
1.37
4.73
5.3
5.4
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
42
205
2.10
4.70
1.4
1.3
ug/g
322.9
311.5
0.13
20
113
(3014007) Fractional oxyhemoglobin in Arterial blood
69
400
1.78
4.67
4.7
7.9
%
94.8
93.8
1.11
69
395
(3020779) Urea [Moles/volume] in Serum or Plasma
75
446
1.74
4.65
9.3
4.7
mmol/l
9.7
7.5
1.80
69
424
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
24
92
2.65
4.59
2.2
4.5
u/ml
16.5
61.3
—
6
27
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
44
221
2.04
4.57
1.3
1.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
93
592
1.63
4.49
3.4
3.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
74
445
1.72
4.42
1.3
1.2
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
48
256
1.92
4.24
1.7
2.1
nmol/l
13.4
12.0
0.49
41
232
(3002385) Erythrocyte distribution width [Ratio]
746
6874
1.39
4.19
16.0
12.9
%
13.4
13.6
5.17
733
6720
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
63
375
1.73
3.93
1.5
1.6
mg/l
2.4
4.0
0.50
42
266
(3036071) Salmonella sp Ab [Titer] in Serum
10
24
4.20
3.89
1.1
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
101
684
1.53
3.77
1.2
1.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
104
711
1.52
3.72
3.5
2.8
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
27
122
2.25
3.70
3.5
1.5
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
77
495
1.60
3.61
2.1
2.2
ug/l
3.8
6.8
2.03
63
445
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
92
619
1.54
3.55
1.6
2.0
ml/min/173m2
68.5
72.0
0.32
33
249
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
12
36
3.36
3.48
5.8
1.3
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
453
3951
1.28
3.47
3.5
3.4
estimate
0.0
0.0
0.80
66
688
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
412
3553
1.28
3.45
3.8
3.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
76
493
1.59
3.44
1.3
1.4
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
937
9124
2.23
3.44
20.4
16.2
e9/l
259.3
261.2
0.40
917
8905
(3021601) Nitrite [Presence] in Urine by Test strip
449
3916
1.28
3.42
4.7
4.5
estimate
0.0
0.0
0.50
68
710
(1001926) Buprenorphine [Presence] in Urine by Screen method
40
217
1.88
3.41
2.7
1.4
—
—
—
0
0
(3024731) MCV [Entitic volume]
937
9127
2.21
3.38
20.4
16.1
fl
91.3
90.8
2.78
932
9006
(3011288) Drugs identified in Urine by Screen method
35
182
1.96
3.37
5.0
1.7
—
—
—
0
0
(3035941) MCH [Entitic mass]
937
9129
2.20
3.34
20.4
16.1
pg
30.4
30.2
3.09
932
9007
(3026361) Erythrocytes [#/volume] in Blood
937
9130
2.20
3.33
20.5
16.2
e12/l
4.4
4.5
6.34
914
8881
(3023368) Bacteria identified in Blood by Culture
198
1554
1.35
3.30
4.7
3.5
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
937
9132
2.19
3.29
20.5
16.2
e9/l
6.4
6.5
1.04
917
8884
(3035350) Ketones [Presence] in Urine by Test strip
443
3871
1.27
3.28
3.6
3.4
estimate
0.0
0.0
0.00
66
707
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
262
2144
1.31
3.26
2.1
2.0
u/l
168.5
199.2
0.33
240
2011
(3000963) Hemoglobin [Mass/volume] in Blood
937
9134
2.18
3.25
20.5
16.3
g/l
133.5
134.7
2.33
932
9013
(40761511) CBC panel - Blood by Automated count
891
8565
1.58
3.24
11.8
10.1
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
115
828
1.44
3.20
3.0
1.9
%
22.6
23.8
0.52
107
710
(3020891) Body temperature
45
259
1.77
3.19
5.3
4.5
—
—
—
0
0
(3000492) Spirometry study
108
769
1.46
3.18
1.2
1.5
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
273
2253
1.30
3.18
2.5
2.7
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
123
899
1.42
3.15
2.8
1.8
g/l
2.4
2.4
0.24
116
835
(3021960) Folate [Moles/volume] in Serum or Plasma
202
1603
1.33
3.12
1.5
1.5
nmol/l
24.7
22.0
1.67
173
1360
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
95
663
1.48
3.10
1.2
1.2
iu/ml
147.8
152.0
0.03
30
273
(3025130) Human papilloma virus identified in Specimen
28
139
2.04
3.08
1.5
1.8
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
160
1229
1.36
3.06
3.9
3.0
ng/l
135.2
405.8
1.09
108
859
(1002224) Polysomnography panel
60
379
1.62
3.05
1.1
1.1
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
214
1720
1.31
3.01
2.2
2.0
mg/l
2.5
2.9
2.62
181
1446
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
902
8712
1.60
3.01
10.4
9.0
u/l
23.6
24.6
1.47
884
8419
(40760892) CBC W Ordered Manual Differential panel - Blood
228
1853
1.30
2.96
3.2
4.4
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
177
1390
1.34
2.93
2.8
2.2
e6/l
7.1
7.7
0.17
153
1217
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
280
2341
1.28
2.91
2.4
2.1
u/l
59.5
56.9
0.57
253
2136
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
599
5468
1.25
2.89
2.9
2.8
u/l
34.8
40.4
1.13
563
5112
(3052851) Hemolysis interference index of Serum or Plasma
36
200
1.83
2.89
3.5
3.2
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
6
9
6.70
2.87
2.0
1.1
ng/l
99.7
104.5
—
6
9
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
37
208
1.81
2.86
3.0
2.7
u/ml
22.3
697.6
0.53
27
182
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
39
223
1.78
2.85
1.6
1.7
g/l
1.3
1.5
0.45
34
196
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
82
567
1.49
2.82
2.5
2.4
au/ml
17.5
19.8
0.14
13
28
(3013139) Helicobacter pylori Ag [Presence] in Stool
85
593
1.48
2.80
1.4
1.2
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
97
695
1.44
2.79
2.0
2.0
nmol/l
364.7
374.2
0.16
90
637
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
29
152
1.94
2.77
1.1
1.3
u/l
36.7
27.8
0.63
21
126
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
64
424
1.55
2.69
1.5
1.4
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
37
213
1.77
2.66
1.9
2.0
%
165.0
170.9
0.15
37
203
(3005033) Fetal Nuchal fold Thickness US
34
191
1.81
2.65
1.6
1.4
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
177
2189
0.77
2.64
3.7
3.8
mg/mmol
12.2
8.4
0.29
96
1292
(3047352) Trisomy 18 risk [Likelihood] in Fetus
34
192
1.80
2.61
1.6
1.4
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
75
519
1.48
2.59
1.3
1.3
iu/l
33.7
31.1
0.30
66
438
(3027944) Amphetamines [Presence] in Urine
46
285
1.65
2.56
3.3
1.4
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
394
3468
1.23
2.54
8.7
8.2
e9/l
0.0
0.0
0.59
294
2825
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
80
565
1.45
2.50
2.6
3.3
pmol/l
4.4
4.6
1.22
73
494
(40765089) Chromosome analysis panel - Blood by G-banded
7
16
4.40
2.47
1.1
1.0
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
15
63
2.40
2.47
4.0
3.3
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
8
21
3.83
2.46
1.8
1.1
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
8
21
3.83
2.46
1.8
1.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
34
196
1.76
2.46
1.7
1.5
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
40
242
1.68
2.44
1.9
1.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
46
289
1.62
2.44
3.3
1.4
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
25
131
1.93
2.42
1.1
1.1
u/ml
5.4
4.5
0.08
14
62
(3027008) Opiates [Presence] in Urine
46
290
1.62
2.41
3.3
1.4
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
131
1016
1.34
2.36
2.9
1.9
umol/l
13.7
14.0
0.23
123
925
(3028300) Cannabinoids [Presence] in Urine
46
292
1.60
2.35
3.3
1.4
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
34
199
1.73
2.34
2.4
1.4
g/l
38.9
38.9
0.00
29
180
(3003396) Base excess in Arterial blood by calculation
87
633
1.41
2.33
4.4
6.7
mmol/l
0.8
1.1
0.25
76
508
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
22
112
1.99
2.32
1.0
1.2
%
127.0
118.5
0.76
22
102
(3016879) Cocaine [Presence] in Urine
43
270
1.62
2.30
3.5
1.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
90
661
1.40
2.29
1.7
1.5
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
202
1668
1.27
2.28
1.7
1.5
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
12
47
2.57
2.27
1.0
1.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
91
671
1.39
2.26
1.7
1.6
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
117
899
1.34
2.25
1.7
1.7
%
1.4
1.3
0.83
104
808
(3045683) HLA typing for celiac disease panel - Blood or Tissue
14
60
2.35
2.22
1.0
1.0
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
23
121
1.92
2.22
1.3
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
23
121
1.92
2.22
1.3
1.2
—
—
—
0
0
(4306422)
22
114
1.95
2.22
1.0
1.2
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
18
87
2.09
2.18
1.1
1.2
%
88.7
96.0
0.85
18
80
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
23
122
1.91
2.17
1.1
1.2
u/ml
1.3
3.9
—
6
35
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
35
212
1.68
2.16
2.3
1.6
g/l
0.3
0.5
0.28
29
195
(3027945) Reticulocytes/100 erythrocytes in Blood
85
625
1.40
2.16
1.9
2.5
%
1.7
1.8
0.86
73
553
(3003694) ABO and Rh group [Type] in Blood
256
2186
1.23
2.15
1.6
1.5
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
184
1515
1.27
2.13
1.4
1.3
u/ml
5.1
13.2
2.19
59
618
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
11
43
2.58
2.10
1.6
1.5
u/l
11.7
6.5
—
6
22
(4010399)
76
551
1.41
2.09
1.5
1.4
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
227
1919
1.24
2.09
2.2
2.2
umol/l
7411.4
5883.0
0.19
201
1671
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
19
96
2.00
2.06
1.1
1.1
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
30
177
1.72
2.04
2.7
3.1
u/ml
15.4
28.0
1.45
30
172
(3019150) Specific gravity of Urine by Refractometry
202
1690
1.25
2.04
4.2
3.9
kg/l
1.0
1.0
0.13
21
239
(3005719) IgG [Mass/volume] in Serum or Plasma
75
546
1.41
2.03
2.0
2.6
g/l
10.6
10.4
0.18
66
504
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
11
44
2.52
2.01
1.0
1.1
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
23
126
1.85
1.99
1.0
1.1
u/ml
0.2
2.2
1.04
11
49
(3021447) Carbon dioxide [Partial pressure] in Venous blood
67
480
1.43
1.98
4.1
2.5
kpa
5.9
5.8
0.41
67
466
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
109
846
1.33
1.98
1.9
1.7
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
26
149
1.77
1.96
1.2
1.1
u/ml
0.2
1.3
—
10
52
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
49
331
1.51
1.95
1.6
1.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
22
120
1.85
1.94
1.2
1.5
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
191
1599
1.24
1.91
1.4
1.3
iu/ml
31.3
32.7
0.06
51
531
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
36
229
1.59
1.87
2.4
1.5
g/l
10.1
10.2
0.08
31
207
(4198724)
8
28
2.87
1.86
2.0
1.3
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
36
230
1.59
1.84
2.3
1.5
g/l
2.9
3.0
0.59
31
193
(3033799) Differential panel - Peritoneal fluid
6
17
3.54
1.84
1.3
1.4
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
66
479
1.41
1.83
4.2
2.4
mmol/l
2.1
2.2
0.09
60
387
(3012516) Albumin [Mass/volume] in Urine
175
2077
0.81
1.80
3.0
3.1
mg/l
501.1
296.9
0.18
98
1215
(1761482) Bacteria [#/volume] in Urine by Culture
6
150
0.40
1.78
3.3
3.4
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
30
185
1.64
1.77
1.2
1.3
u/l
16.3
13.0
0.39
25
148
(3047007) Chlamydophila sp Ab [Presence] in Serum
24
139
1.75
1.77
1.3
1.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
24
139
1.75
1.77
6.2
1.5
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
14
67
2.11
1.76
1.0
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
10
42
2.40
1.68
1.1
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
50
352
1.44
1.66
1.9
1.6
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
44
302
1.48
1.66
1.4
1.6
mu/l
254.9
320.8
1.34
34
272
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
22
127
1.75
1.65
1.1
1.2
u/ml
3.7
5.6
—
9
42
(3013826) Glucose [Moles/volume] in Serum or Plasma
457
4198
1.17
1.64
4.2
3.7
mmol/l
6.3
6.6
2.50
428
3873
(3020630) Protein [Mass/volume] in Serum or Plasma
69
516
1.36
1.63
2.0
2.3
g/l
66.0
67.6
1.17
62
478
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
211
1817
1.21
1.61
1.6
1.6
mg/l
1.0
0.9
0.17
154
1364
(4268621)
16
84
1.92
1.60
2.4
2.3
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
6
20
3.01
1.58
1.0
1.0
u/ml
66.5
37.2
—
6
20
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
7
156
0.44
1.56
1.1
1.9
nmol/l
0.7
0.9
—
7
132
(3000494) Fungus identified in Specimen by Culture
110
886
1.27
1.55
1.4
1.4
—
—
—
0
0
(4094501)
33
218
1.53
1.50
1.1
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
24
147
1.65
1.48
1.2
1.2
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
39
555
0.69
1.48
4.6
4.1
%
0.1
0.8
—
7
113
(3012501) Base excess in Blood by calculation
21
124
1.71
1.48
6.2
2.5
mmol/l
1.6
2.8
1.49
16
86
(3000330) Specific gravity of Urine by Test strip
20
329
0.60
1.47
1.8
2.7
—
—
—
0
0
(3026782) Osmolality of Urine
152
1279
1.22
1.47
2.6
2.2
mosm/kgh2o
519.4
531.8
0.28
120
1078
(3017181) Myelocytes/100 leukocytes in Blood
44
611
0.71
1.46
4.4
3.9
%
2.0
0.9
—
10
152
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
23
140
1.66
1.46
1.1
1.1
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
35
237
1.49
1.43
1.6
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
35
237
1.49
1.43
1.6
1.4
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
61
458
1.35
1.43
2.2
2.0
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
36
246
1.48
1.42
2.3
1.5
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
36
246
1.48
1.42
2.3
1.5
g/l
3.4
3.8
2.00
31
187
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
36
246
1.48
1.42
2.3
1.5
g/l
6.9
7.4
1.25
31
198
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
35
238
1.49
1.41
1.6
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
35
238
1.49
1.41
1.6
1.4
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
9
40
2.26
1.40
1.7
1.3
—
—
—
0
0
(4027681)
10
46
2.19
1.40
1.1
1.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
36
247
1.48
1.39
1.7
1.5
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
7
29
2.42
1.39
1.0
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
11
53
2.09
1.39
1.5
2.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
21
127
1.67
1.37
2.4
2.5
u/ml
0.3
0.4
—
10
70
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
53
394
1.37
1.34
2.5
2.3
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
13
68
1.92
1.33
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
13
68
1.92
1.33
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
13
68
1.92
1.33
1.2
1.1
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
71
554
1.30
1.30
3.8
2.6
ng/l
80.8
69.6
0.59
64
496
(3034426) Prothrombin time (PT)
6
24
2.51
1.30
1.2
1.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
62
475
1.33
1.30
1.1
1.0
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
8
34
2.36
1.29
1.1
1.3
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
8
34
2.36
1.29
4.6
4.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
13
69
1.90
1.29
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
13
69
1.90
1.29
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
13
69
1.90
1.29
1.2
1.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
43
585
0.72
1.29
4.5
4.0
%
0.1
0.1
—
8
133
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
55
415
1.35
1.27
1.5
1.5
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
279
2510
1.16
1.26
2.8
2.7
u/l
34.8
29.2
0.36
257
2396
(3022313) Gas panel - Capillary blood
15
251
0.59
1.22
3.5
2.5
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
5
19
2.64
1.21
1.2
1.0
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
8
37
2.17
1.21
1.8
1.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
188
2135
0.85
1.20
2.9
2.9
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
17
102
1.68
1.16
1.0
1.0
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
32
224
1.44
1.15
1.1
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
20
126
1.60
1.15
1.1
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
73
583
1.27
1.15
1.6
1.4
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
12
65
1.86
1.13
1.1
1.1
u/l
50.7
53.5
—
7
45
(3015183) Erythrocyte sedimentation rate
10
51
1.97
1.11
1.3
1.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
114
961
1.21
1.11
1.7
1.6
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
46
347
1.34
1.09
1.7
1.4
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
5
21
2.39
1.09
3.6
2.5
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
252
2275
1.15
1.08
1.6
1.6
mmol/l
1.3
1.4
1.32
224
1921
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
769
7454
1.16
1.06
4.7
5.1
mmol/mol
37.4
39.0
6.87
722
6959
(3016650) Hepatitis A virus Ab [Presence] in Serum
17
105
1.63
1.06
1.0
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
57
446
1.30
1.06
2.8
2.8
ug/l
0.7
0.7
0.18
37
281
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
43
323
1.35
1.06
2.3
2.1
u/l
3573.5
2603.2
0.11
15
134
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
25
170
1.48
1.05
1.6
1.2
mmol/l
3.3
3.7
3.14
25
158
(3023520) Reticulocytes [#/volume] in Blood
59
465
1.29
1.04
2.2
2.8
e9/l
66.9
71.5
0.64
39
344
(3009343) pH of Capillary blood
23
334
0.68
1.03
3.2
2.5
ph
7.4
7.4
—
6
49
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
22
322
0.68
1.03
3.2
2.6
mmol/l
2.4
1.8
0.46
15
239
(3002179) Metamyelocytes/100 leukocytes in Blood
43
561
0.76
1.02
3.4
3.9
%
1.4
0.6
—
8
108
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
10
53
1.90
1.01
1.0
1.1
mg/l
256.4
239.6
—
10
44
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
10
53
1.90
1.01
3.7
6.8
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
10
53
1.90
1.01
1.0
1.0
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
81
975
0.82
0.99
3.7
4.2
%
34.8
33.1
0.80
49
664
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
5
23
2.18
0.98
1.6
1.2
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
5
23
2.18
0.98
1.6
1.3
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
76
624
1.24
0.97
3.3
4.4
u/l
290.4
227.4
0.44
70
597
(3023419) Bacteria identified in Sputum by Culture
12
69
1.75
0.96
1.5
3.0
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
14
85
1.66
0.94
1.4
1.7
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
11
62
1.78
0.94
2.5
2.7
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
26
184
1.42
0.92
1.5
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
20
134
1.50
0.92
1.5
1.5
—
—
—
0
0
(4062490)
13
78
1.68
0.92
1.7
1.4
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
23
160
1.45
0.89
2.0
1.5
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
22
152
1.46
0.88
1.8
1.5
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
26
186
1.41
0.88
1.6
1.3
mg/l
422.5
470.7
0.47
26
175
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
106
911
1.18
0.87
1.3
1.3
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
6
30
2.01
0.87
1.7
1.1
g/l
0.3
0.3
—
6
23
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
6
30
2.01
0.87
1.5
1.1
%
120.8
106.9
—
6
23
(3034860) Kappa light chains.free [Mass/volume] in Serum
23
162
1.43
0.85
3.5
2.9
mg/l
40.3
61.5
0.34
16
128
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
23
162
1.43
0.85
3.5
2.9
mg/l
25.7
24.7
0.05
16
128
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
850
8336
1.17
0.84
5.0
4.7
mmol/l
2.9
2.9
0.41
801
7760
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
8
45
1.78
0.84
1.6
1.8
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
36
275
1.32
0.83
4.0
8.6
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
25
180
1.40
0.82
1.9
2.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
17
113
1.51
0.82
4.2
2.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
8
47
1.71
0.80
1.0
1.3
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
229
2096
1.12
0.79
4.2
3.8
estimate
0.0
0.0
0.80
65
704
(3003740) Influenza virus B Ag [Presence] in Specimen
22
156
1.42
0.79
1.1
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
22
156
1.42
0.79
1.1
1.1
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
24
0.00
0.79
0.0
2.1
—
2.3
—
0
10
(21494814) CD8 cells/100 lymphocytes in Specimen
0
24
0.00
0.79
0.0
2.0
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
6
33
1.82
0.79
1.3
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
11
66
1.67
0.79
6.7
4.0
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
83
706
1.19
0.78
17.1
20.1
inr
1.2
1.3
—
6
83
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
24
174
1.39
0.77
1.2
1.2
—
1.8
—
0
15
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
12
186
0.64
0.77
1.5
1.5
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
54
441
1.24
0.76
1.1
1.1
—
219.4
—
0
9
(3004119) Hemoglobin [Mass/volume] in Venous blood
41
324
1.28
0.76
2.8
2.4
g/l
129.0
129.9
0.09
41
317
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
9
53
1.70
0.75
1.0
1.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
9
53
1.70
0.75
1.2
1.4
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
14
91
1.55
0.75
1.3
1.4
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
71
598
1.20
0.75
4.6
4.0
%
24.2
21.2
0.93
37
254
(3016018) Differential panel - Cerebral spinal fluid
12
75
1.61
0.75
2.4
1.6
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
5
24
2.09
0.74
1.8
1.7
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
5
25
2.01
0.72
1.2
1.0
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
5
25
2.01
0.72
1.0
1.0
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
9
56
1.61
0.72
1.0
1.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
7
40
1.76
0.71
3.0
1.5
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
9
57
1.58
0.71
1.2
1.2
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
5
26
1.93
0.70
1.4
1.4
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
15
101
1.49
0.70
1.7
1.6
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
15
101
1.49
0.70
1.7
1.9
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
45
551
0.81
0.69
2.8
2.7
e9/l
4.1
4.0
0.12
29
449
(3019060) Gas panel - Arterial blood
43
348
1.25
0.67
3.4
4.3
—
—
—
0
0
(3013512) EKG study
195
2122
0.90
0.67
3.2
3.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
207
2244
0.90
0.66
3.2
3.0
mmol/l
6.6
7.0
0.90
177
1908
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
11
70
1.58
0.65
1.2
1.1
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
7
44
1.60
0.65
1.0
1.4
—
32.0
—
0
5
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
284
2659
1.10
0.64
2.8
2.9
ng/l
20.3
44.3
0.90
149
1601
(3000475) Leukocytes [#/volume] in Synovial fluid
21
155
1.36
0.63
1.5
1.7
e6/l
6657.1
11650.8
0.57
16
113
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
25
190
1.32
0.63
2.3
2.1
ug/l
1025.3
222.5
0.60
20
175
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
15
104
1.45
0.62
1.5
1.6
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
15
104
1.45
0.62
1.4
1.1
u/ml
153.7
234.7
—
10
64
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
18
245
0.73
0.62
2.1
1.7
—
—
—
0
0
(40768793) Breast Pathology biopsy report
35
280
1.26
0.61
1.2
1.3
—
—
—
0
0
(40768441) Liver Pathology biopsy report
8
50
1.60
0.61
1.0
1.4
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
830
8162
1.13
0.60
4.3
4.2
mmol/l
1.6
1.6
6.66
781
7590
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
9
140
0.64
0.60
1.3
1.5
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
8
51
1.57
0.60
1.1
1.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
8
51
1.57
0.60
1.5
1.3
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
8
51
1.57
0.60
1.5
1.3
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
8
51
1.57
0.60
1.5
1.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
60
702
0.84
0.60
4.5
3.5
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
0
23
0.00
0.58
0.0
2.1
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
52
438
1.20
0.58
1.6
1.7
g/l
1.5
1.4
0.09
47
405
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
51
429
1.20
0.58
2.5
2.2
ng/l
105.7
144.8
0.84
44
393
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
8
54
1.49
0.57
1.1
1.0
mg/l
297.0
297.7
—
8
48
(3023410) Appearance of Cerebral spinal fluid
12
81
1.49
0.57
2.4
1.8
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
19
141
1.35
0.56
1.2
1.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
275
2588
1.09
0.56
4.6
6.6
inr
1.1
1.2
0.35
72
800
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
13
90
1.45
0.55
1.1
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
15
107
1.41
0.55
1.5
1.5
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
15
107
1.41
0.55
1.3
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
71
619
1.16
0.54
1.8
1.8
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
6
38
1.58
0.54
1.2
1.2
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
9
63
1.43
0.52
1.6
1.7
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
9
135
0.66
0.52
1.9
1.4
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
17
126
1.36
0.52
1.9
3.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
135
1234
1.11
0.51
1.7
1.6
nmol/l
1290.2
1249.0
0.23
108
931
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
833
8210
1.11
0.51
4.4
4.2
mmol/l
4.9
4.9
0.69
785
7673
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
84
747
1.14
0.50
4.6
4.3
ug/l
2.1
1.9
0.33
76
678
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
17
224
0.75
0.50
1.9
1.6
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
35
289
1.22
0.49
1.3
1.3
miu/ml
197.5
244.5
0.28
13
146
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
19
145
1.32
0.49
1.3
1.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
15
110
1.37
0.49
1.5
1.4
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
7
46
1.53
0.48
1.4
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
11
76
1.45
0.48
1.1
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
82
917
0.88
0.47
1.3
1.4
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
7
47
1.49
0.47
1.4
1.2
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
7
47
1.49
0.47
2.0
1.4
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
10
68
1.48
0.47
1.2
1.7
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
191
1784
1.09
0.47
2.4
2.5
ng/l
803.8
810.4
0.01
162
1470
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
801
7888
1.09
0.46
3.9
3.7
mmol/l
1.2
1.3
2.07
754
7287
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
807
7951
1.09
0.46
4.2
4.3
mmol/l
5.6
5.8
6.57
749
7328
(3017817) Protein [Mass] in Urine collected for unspecified duration
7
50
1.40
0.45
4.9
2.6
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
7
50
1.40
0.45
1.0
1.0
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
32
265
1.21
0.45
2.1
2.0
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
10
69
1.45
0.44
1.0
1.2
nmol/l
413.6
425.4
—
10
64
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
10
69
1.45
0.44
8.3
3.0
u/ml
21.3
51.8
—
10
69
(3037121) Protein [Mass/volume] in Urine
26
211
1.24
0.44
3.0
2.9
g/l
0.1
0.3
—
10
77
(3026389) Candida sp identified in Specimen by Organism specific culture
14
104
1.35
0.43
1.0
1.4
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
16
122
1.32
0.42
1.3
1.2
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
5
32
1.57
0.42
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
5
32
1.57
0.42
1.0
1.0
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
6
95
0.63
0.42
1.0
1.0
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
8
58
1.38
0.41
1.4
1.4
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
15
0.00
0.41
0.0
2.7
—
0.7
—
0
15
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
16
0.00
0.41
0.0
1.9
—
—
—
0
0
(44806420)
0
16
0.00
0.41
0.0
2.3
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
0
17
0.00
0.40
0.0
1.8
—
5.9
—
0
11
(3006462) Nitrate [Presence] in Urine
5
34
1.47
0.40
2.0
3.0
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
8
60
1.34
0.40
1.1
1.1
—
—
—
0
0
(4281824)
7
103
0.68
0.39
1.1
1.1
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
8
61
1.31
0.39
1.0
1.1
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
14
106
1.33
0.39
2.8
2.1
%
14.3
16.6
—
8
51
(3045788) Cell count panel - Pleural fluid
5
37
1.35
0.37
1.2
1.2
—
—
—
0
0
(44813793)
10
72
1.39
0.37
1.0
1.0
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
29
245
1.19
0.35
1.6
1.9
iu/l
1.6
5.5
—
8
99
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
15
117
1.29
0.35
1.4
1.1
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
6
44
1.37
0.34
1.2
2.1
—
1.6
—
0
5
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
152
1612
0.93
0.32
1.6
1.6
pmol/l
524.6
29120910.2
1.82
128
1353
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
6
47
1.28
0.32
1.0
1.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
17
138
1.24
0.30
1.5
1.6
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
102
951
1.08
0.29
1.7
1.8
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
18
149
1.21
0.28
1.2
1.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
18
149
1.21
0.28
2.4
2.5
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
8
63
1.27
0.27
1.5
1.3
—
—
—
0
0
(3019225) pH of Specimen
68
739
0.91
0.27
5.2
3.3
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
8
65
1.23
0.27
1.3
1.6
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
104
1.25
0.26
1.2
1.6
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
45
405
1.12
0.26
1.6
1.5
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
9
75
1.20
0.25
1.1
1.1
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
11
87
1.27
0.24
1.6
1.4
%
54.4
61.7
0.42
11
87
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
9
77
1.17
0.24
1.1
1.6
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
26
227
1.15
0.24
1.3
1.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
313
3041
1.04
0.24
3.7
3.5
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
5
38
1.32
0.23
1.8
1.7
ug/l
94.5
23.2
—
5
38
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
5
38
1.32
0.23
1.0
1.1
miu/ml
1600.0
1777.8
—
5
38
(4035726)
71
661
1.08
0.22
1.3
1.3
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
14
167
0.84
0.21
1.4
1.7
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
16
135
1.19
0.21
1.0
1.0
u/ml
0.7
2.1
—
8
61
(4211845)
5
42
1.19
0.21
2.0
2.6
—
—
—
0
0
(3011648) Oxygen content in Venous blood
5
42
1.19
0.21
2.2
1.4
%
10.5
10.1
—
5
42
(40768800) Prostate Pathology biopsy report
5
42
1.19
0.21
1.6
1.1
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
11
0.00
0.21
0.0
1.1
—
1.0
—
0
11
(3019174) dRVVT (LA screen)
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3036312) Salmon IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
0.0
—
0
5
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
10
0.00
0.21
0.0
4.1
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
10
0.00
0.21
0.0
4.7
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
2.3
—
47.6
—
0
12
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
0
12
0.00
0.21
0.0
2.4
—
2.8
—
0
5
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
9
111
0.81
0.20
2.4
2.2
mmol/l
22.7
25.2
—
9
100
(3035320) C reactive protein [Mass/volume] in Body fluid
6
49
1.23
0.20
1.2
2.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
36
327
1.10
0.19
1.9
1.7
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
25
280
0.89
0.19
1.3
1.5
—
—
—
0
0
(3036603) Volume of Urine
7
58
1.21
0.18
1.7
1.6
—
2063.5
—
0
12
(3045142) Bone marrow Pathology biopsy report
7
61
1.15
0.17
1.0
1.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
16
138
1.16
0.17
1.6
1.6
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
8
70
1.14
0.16
1.1
1.6
g/l
1.0
1.0
—
8
70
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
8
72
1.11
0.16
1.0
1.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
23
207
1.11
0.15
1.3
1.2
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
11
93
1.18
0.14
1.0
1.0
g/l
1.4
1.5
0.22
11
87
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
84
1.19
0.14
1.1
1.6
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
16
179
0.89
0.12
1.3
1.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
14
124
1.13
0.11
1.8
1.7
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
5
44
1.14
0.10
1.2
1.5
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
5
44
1.14
0.10
2.2
2.2
—
829.9
—
0
11
(21494434) Karyotype in Bone marrow
5
46
1.09
0.09
1.0
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
47
493
0.95
0.09
1.9
2.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
10
87
1.15
0.09
1.2
1.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
10
87
1.15
0.09
1.3
1.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
11
97
1.14
0.09
1.2
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
12
134
0.89
0.08
1.2
1.7
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
5
62
0.81
0.08
1.4
5.0
mmol/l
6.0
7.0
—
5
48
(4146454)
5
63
0.79
0.08
1.8
2.7
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
5
65
0.77
0.08
1.0
1.5
mmol/l
8.1
9.7
—
5
12
(3005988) Vibrio sp identified in Specimen by Organism specific culture
10
88
1.14
0.08
1.2
1.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
7
66
1.06
0.08
1.1
1.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
8
74
1.08
0.07
2.6
2.2
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
8
76
1.05
0.07
1.1
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
8
77
1.04
0.07
2.0
2.2
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
9
86
1.05
0.07
1.1
1.1
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
9
87
1.03
0.07
1.2
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
35
334
1.05
0.07
1.1
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
9
102
0.88
0.06
1.3
1.2
nmol/l
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
313
3160
0.99
0.06
2.3
2.7
—
—
—
0
0
(4034850)
31
296
1.05
0.06
7.5
8.6
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
10
90
1.11
0.05
1.2
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
10
90
1.11
0.05
1.2
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
10
90
1.11
0.05
1.2
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
10
110
0.91
0.05
1.3
1.1
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
16
150
1.07
0.04
4.6
3.5
e9/l
4.6
3.9
0.61
16
150
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
12
111
1.08
0.04
1.4
1.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
32
310
1.03
0.03
1.9
1.8
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
12
113
1.06
0.02
1.7
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
12
114
1.05
0.00
1.6
1.4
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
13
126
1.03
0.00
2.0
1.9
g/l
119.1
132.6
—
8
83
(3014051) Protein [Presence] in Urine by Test strip
16
164
0.98
0.00
1.4
1.8
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
16
157
1.02
0.00
4.6
3.8
%
60.9
57.4
0.73
16
157
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
12
119
1.01
0.00
1.4
1.3
nmol/l
—
0.6
—
0
9
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
10
95
1.05
0.00
1.1
1.5
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
9
91
0.99
0.00
1.0
1.6
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
9
0.00
0.00
0.0
4.7
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
6
69
0.87
0.00
1.0
1.1
—
—
—
0
0
(3032700) Glomerular basement membrane Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
6
65
0.92
0.00
1.0
1.6
nmol/l
1.4
1.3
—
6
58
(3023436) Glucagon [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
198.6
—
0
5
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
9
95
0.95
0.00
2.4
2.0
kpa
7.9
8.2
—
9
88
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
11.2
—
0
5
(46236302) HLA-C [Type] by High resolution typing
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012898) Urea [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.3
—
221.0
—
0
6
(3013945) Hepatitis B virus e Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
6.2
—
0
7
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(4024509)
6
59
1.02
0.00
1.5
1.4
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44790049)
7
70
1.00
0.00
1.3
1.5
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
7
0.00
0.00
0.0
5.0
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
6
65
0.92
0.00
1.2
1.2
—
72.3
—
0
6
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
7
0.00
0.00
0.0
1.1
—
7.6
—
0
7
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
3.1
—
35.4
—
0
7
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
6
59
1.02
0.00
4.5
1.8
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
8
0.00
0.00
0.0
2.3
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
9.3
—
0
5
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(44790048)
7
70
1.00
0.00
1.3
1.5
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013862) HLA-DP [Type]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806118)
7
70
1.00
0.00
1.3
1.5
—
—
—
0
0
(44790047)
7
70
1.00
0.00
1.3
1.5
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
6.3
—
0.2
—
0
8
(1617658) Protocol used for examination of sentinel lymph nodes
9
99
0.91
0.00
1.0
1.1
—
—
—
0
0
(40758358) Immune stain study
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
2.1
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: Z21_PROCED_PURPO_OTH_REMED_HEALTH_STATE – Procedures for purposes other than remedying health state
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).